According to recent data by the American Heart Association, Coronary Artery Disease (CAD) has a prevalence of 6.9% in the US population . In 2002, 494,382 people died in the USA from the effects of CAD with a cost that reached 142.1 billion dollars in 2005 . It is well established that patients with evidence of myocardial viability and target vessels for revascularization live longer with surgical revascularization as opposed to medical management especially if they have severe left ventricular dysfunction . However, patients who reach end-stage ischemic-cardiomyopathy without evidence of viability do not benefit from revascularization . This chapter discusses transplantation as treatment for these patients with end-stage ischemic cardiomyopathy.
|Original language||English (US)|
|Title of host publication||Coronary Artery Disease|
|Subtitle of host publication||New Approaches without Traditional Revascularization|
|Number of pages||15|
|ISBN (Print)||1846284600, 9781846284601|
|State||Published - Apr 1 2012|